摘要 |
The present invention relates to compounds of general formula I
wherein the groups and radicals B, k, L, U,V, W, X, Y, Z, R 1 , R 2 , have the meanings given in claim 1. Moreover the invention relates to pharmaceutical compositions containing at least one compound according to the invention. By virtue of their MCH-receptor antagonistic activity the pharmaceutical compositions according to the invention are suitable for the treatment of metabolic disorders and/or eating disorders, particularly obesity, bulimia, anorexia, hyperphagia and diabetes. |
申请人 |
BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
发明人 |
STENKAMP, DIRK;MUELLER, STEPHAN, GEORG;LEHMANN-LINTZ, THORSTEN;ROTH, GERALD, JUERGEN;KLEY, JOERG;RUDOLF, KLAUS;HECKEL, ARMIN;SCHINDLER, MARCUS;LOTZ, RALF |